Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adiponectin Measurement
|
70 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||
Angina, Unstable
|
21 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Coronary Arteriosclerosis
|
440 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Coronary Artery Disease
|
1577 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Coronary heart disease
|
1178 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Degenerative polyarthritis
|
247 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Diabetic Nephropathy
|
238 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Ischemic stroke
|
704 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Malignant neoplasm of prostate
|
1082 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1 | 2015 | 2015 | ||||||
Metabolic Diseases
|
50 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Osteoarthritis, Knee
|
150 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1 | 2015 | 2015 | ||||||
Prostatic Neoplasms
|
31 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Renal Cell Carcinoma
|
288 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
skin fold (abnormality)
|
8 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Splenic Hypoplasia
|
9 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||
Obesity
|
1111 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.701 | 0.440 | 3 | 186842993 | intron variant | G/A | snv | 0.38 | 0.040 | 1.000 | 4 | 2009 | 2019 |